Cargando…

Evaluation of the cardiac amyloidosis clinical pathway implementation: a real-world experience

AIMS: The aim of this study is to evaluate the implementation of the cardiac amyloidosis (CA) clinical pathway on awareness among referring cardiologists, diagnostic delay, and severity of CA at diagnosis. METHODS AND RESULTS: Patients with CA were retrospectively included in this study and divided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brons, Maaike, Muller, Steven A, Rutten, Frans H, van der Meer, Manon G, Vrancken, Alexander F J E, Minnema, Monique C, Baas, Annette F, Asselbergs, Folkert W, Oerlemans, Marish I F J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242028/ https://www.ncbi.nlm.nih.gov/pubmed/35919127 http://dx.doi.org/10.1093/ehjopen/oeac011

Ejemplares similares

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Patterns in the Use of Heart Failure Telemonitoring: Post Hoc Analysis of the e-Vita Heart Failure Trial
por: Brons, Maaike, et al.
Publicado: (2023)

Cardiac amyloidosis: the need for early diagnosis
por: Oerlemans, M. I. F. J., et al.
Publicado: (2019)

Automatic Identification of Patients With Unexplained Left Ventricular Hypertrophy in Electronic Health Record Data to Improve Targeted Treatment and Family Screening
por: Sammani, Arjan, et al.
Publicado: (2022)

Algorithms used in telemonitoring programmes for patients with chronic heart failure: A systematic review
por: Brons, Maaike, et al.
Publicado: (2018)

Developing a personalized remote patient monitoring algorithm: a proof-of-concept in heart failure
por: Moazeni, Mehran, et al.
Publicado: (2023)

Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
por: Numan, Lieke, et al.
Publicado: (2023)

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics
por: Sammani, Arjan, et al.
Publicado: (2021)

Pre-Operative SARS-CoV-2 Testing in Asymptomatic Heart Transplantation Recipients
por: Zwetsloot, Peter-Paul, et al.
Publicado: (2023)

Real-world management of heart failure in the Netherlands: Improving quality of care by simple measures
por: Koudstaal, S., et al.
Publicado: (2018)

Real-World Data and Machine Learning to Predict Cardiac Amyloidosis
por: García-García, Elena, et al.
Publicado: (2021)

Donor-Derived Testicular Germ Cell Cancer in a Heart Transplant Recipient
por: Oerlemans, Marish I.F.J., et al.
Publicado: (2021)

S198: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK
por: Kastritis, Efstathios, et al.
Publicado: (2023)

Automatic multilabel detection of ICD10 codes in Dutch cardiology discharge letters using neural networks
por: Sammani, Arjan, et al.
Publicado: (2021)

One year improvement of exercise capacity in patients with mechanical circulatory support as bridge to transplantation
por: Felix, Susanne E.A., et al.
Publicado: (2021)

Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis
por: Jansen, Mark, et al.
Publicado: (2022)

Real-World LEAP Implementation
por: Koplin, Jennifer J., et al.
Publicado: (2022)

First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience
por: Jeryczynski, G., et al.
Publicado: (2021)

In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study
por: Minnema, Monique C., et al.
Publicado: (2022)

Incorporating structural abnormalities in equivalent dipole layer based ECG simulations
por: Boonstra, Machteld J, et al.
Publicado: (2022)

Real world data on light chain cardiac amyloidosis: Still a delayed diagnosis
por: Chatzileontiadou, Sofia, et al.
Publicado: (2022)

Dutch Physician’s Perspectives on Diagnosis and Treatment of Waldenström’s Macroglobulinemia Before and After the Implementation of a National Guideline
por: Amaador, Karima, et al.
Publicado: (2022)

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
por: Levy, Sonja, et al.
Publicado: (2022)

Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma
por: Braham, Maaike VJ, et al.
Publicado: (2018)

A real-world study on diagnosis and prognosis of light-chain cardiac amyloidosis in Southern China
por: Wu, Zhijian, et al.
Publicado: (2021)

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study
por: Lebel, Eyal, et al.
Publicado: (2023)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial
por: Minnema, Monique C., et al.
Publicado: (2019)

Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial
por: Minnema, Monique C., et al.
Publicado: (2022)

Validity and success rate of noninvasive mean arterial blood pressure measurements in cf‐LVAD patients: A technical review
por: Lankheet, Steven, et al.
Publicado: (2022)

Amyloidosis
por: Reddy, D. J.
Publicado: (1951)

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
por: Brito, Dulce, et al.
Publicado: (2023)

Challenges in Procalcitonin Implementation in the Real-World
por: Nguyen, Cynthia T, et al.
Publicado: (2018)

Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal
por: Ando, Yukio, et al.
Publicado: (2023)

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
por: Braham, Maaike V. J., et al.
Publicado: (2018)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain
por: Schulz, Martin, et al.
Publicado: (2022)

Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings
por: Dziopa, Katarzyna, et al.
Publicado: (2022)

P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS
por: Minnema, Monique, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6gdumsau6sviikdu25lvvdo7bc